{"id":"18f-fapi-74-pet-ct","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL5723571","moleculeType":null,"molecularWeight":"836.95"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"FAP is a type II transmembrane glycoprotein that is overexpressed in various types of cancer. [18F]FAPI-74 is a radiolabeled peptide that selectively binds to FAP, allowing for the visualization of tumors expressing this protein.","oneSentence":"This drug is a PET imaging agent that targets the fibroblast activation protein (FAP) for the visualization of tumors.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:56:20.960Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Visualization of tumors expressing fibroblast activation protein (FAP)"}]},"trialDetails":[],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"[18F]FAPI-74 PET/CT","genericName":"[18F]FAPI-74 PET/CT","companyName":"SOFIE","companyId":"sofie","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This drug is a PET imaging agent that targets the fibroblast activation protein (FAP) for the visualization of tumors. Used for Visualization of tumors expressing fibroblast activation protein (FAP).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":false,"score":2}}